Krystal Biotech, Inc. (KRYS)
Data as of , from SEC Form 4 filings.
See up to 3 months of KRYS. The 7-day demo opens the 1M and 3M ranges and puts KRYS on your watchlist.
Start 7-day demoLatest KRYS insider trades
Suma Krishnan - OfficerOpen-market sale$184K- Suma Krishnan
About Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. files with the SEC under CIK 0001711279 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
KRYS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 34 | 75,000 | $26.19M |
| Grant or award | 12 | 9,948 | |
| Bona-fide gift | 1 | 3,691 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
KRYS insider transactions (Form 4)
3432 Form 4 filings on record, the earliest from Dec 13, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Suma Krishnan - Officer | Open-market sale | Common Stock | 5,942 | $163.04 | $969K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 8,923 | $163.92 | $1.46M | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 4,723 | $164.92 | $779K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 2,114 | $165.79 | $350K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 798 | $166.96 | $133K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 200 | $168.31 | $34K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 953 | $169.48 | $162K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 727 | $170.43 | $124K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 620 | $171.62 | $106K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 6,302 | $163.07 | $1.03M | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 8,381 | $163.91 | $1.37M | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 4,909 | $164.93 | $810K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 1,977 | $165.82 | $328K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 923 | $166.93 | $154K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 911 | $169.65 | $155K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 957 | $170.47 | $163K | |
| Suma Krishnan - Officer | Open-market sale | Common Stock | 640 | $171.63 | $110K | |
 Krish S. Krishnan - Officer | Open-market sale | Common Stock | 6,302 | $163.07 | $1.03M | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 8,381 | $163.91 | $1.37M | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 4,909 | $164.93 | $810K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 1,977 | $165.82 | $328K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 923 | $166.93 | $154K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 911 | $169.65 | $155K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 957 | $170.47 | $163K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 640 | $171.63 | $110K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 5,942 | $163.04 | $969K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 8,923 | $163.92 | $1.46M | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 4,723 | $164.92 | $779K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 2,114 | $165.79 | $350K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 798 | $166.96 | $133K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 200 | $168.31 | $34K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 953 | $169.48 | $162K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 727 | $170.43 | $124K | |
| Krish S. Krishnan - Officer | Open-market sale | Common Stock | 620 | $171.62 | $106K |
Recent KRYS Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| KRISH KRISHNAN | Director, Officer, 10% Stockholder | 25,000 | $9.29M | View on EDGAR | |
| SUMA KRISHNAN | Director, Officer, 10% Stockholder | 25,000 |
KRYS insider trading FAQ
What is the latest insider trade for KRYS?
Krystal Biotech, Inc. (KRYS) had 9 insider filings in the last 90 days, with the most recent on 2026-09-17. The full record for KRYS runs to 32 Form 4 filings, the earliest from 2024-12-13. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KRYS stock?
No insider purchases of KRYS were filed in the last 90 days.
How many insiders are selling KRYS stock?
34 insider sales of KRYS were filed in the last 90 days, totaling $26.19M.
Where can I see KRYS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KRYS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Dino A. Rossi view on EDGAR
- - Everett Rand Sutherland view on EDGAR
- - Catherine Mazzacco view on EDGAR
- - Christopher Mason view on EDGAR
- - Daniel Janney view on EDGAR
- - Julian S. Gangolli view on EDGAR
- - Suma Krishnan view on EDGAR
- - Krish S. Krishnan view on EDGAR
- - Dino A. Rossi view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where KRYS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KRYS with a 7-day demo
- KRYS on your watchlist
- Every KRYS Form 4 filing on record
- Up to 3 months of KRYS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
